目的观察胺碘酮治疗急性快速型心律失常的疗效及安全性。方法选取2014年3月~2015年3月我院收治的急性快速型心律失常患者108例作为研究对象,将其随机分为研究组和对照组。对照组进行常规治疗,研究组在对照组治疗的基础上采取胺碘酮静脉注射治疗,观察两组疗效及安全性。结果两组的血压与心率均有所改善,其中研究组改善程度明显优于对照组,差异有统计学意义(P<0.05)。研究组治疗后的显效数、总有效数及总有效率显著高于对照组,差异有统计学意义(P<0.05)。结论胺碘酮治疗急性快速型心律失常安全有效,值得临床推荐应用。 Objective To observe the efficacy and safety of amiodarone in the treatment of acute tachyarrhythmia. Methods A total of 108 patients with acute tachyarrhythmia admitted to our hospital from March 2014 to March 2015 were selected as study subjects and randomly divided into study group and control group. Control group for routine treatment, the study group in the control group based on the treatment of intravenous amiodarone treatment, the two groups were observed efficacy and safety. Results The blood pressure and heart rate were improved in both groups, of which the study group was significantly better than the control group, the difference was statistically significant (P <0.05). The effective number, total effective rate and total effective rate of the study group after treatment were significantly higher than those of the control group, with significant difference (P <0.05). Conclusions Amiodarone is safe and effective in the treatment of acute tachyarrhythmia, which is worth recommending.